已收录 273620 条政策
 政策提纲
  • 暂无提纲
Aripiprazole Withdrawal: A Case Report
[摘要] Atypical antipsychotics, including aripiprazole, are effective medications for the treatment of psychotic disorders as well as the augmentation of antidepressants in the treatment of major depression.1 In support of mood augmentation, aripiprazole has this indication through the United States Food and Drug Administration (FDA). Despite the broad use of atypical antipsychotics for various clinical syndromes, discontinuation syndromes related to these second-generation drugs are not well characterized.2
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 精神健康和精神病学
[关键词]  [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文